2-Hydroxypropanoic acid - 4-amino-5-fluoro-3-[5-(4-methyl-1-piperazinyl)-1H-benzimidazol-2-yl]-2(1H)-quinolinone hydrate (1:1:1)(CAS: 915769-50-5)

This compound has a crystalline form and a molecular weight of approximately 753.75 g/mol. It is slightly soluble in water and exhibits low reactivity under normal conditions. The hydrate form increases its solubility. It is stable in air and light, but should be stored in a dry, cool place away from strong acids and bases.

This compound is synthesized by a multi-step process involving condensation reactions, amidation, and quinoline ring formation. The synthesis typically requires the use of specific catalysts and reagents. The yield is around 70-80%, with good selectivity for the desired product.

This compound is primarily used in the pharmaceutical industry as an intermediate for the synthesis of various bioactive compounds. It may also have applications in the polymer industry for specific functional polymers, and in the development of advanced sensors and semiconductors.

When handling this compound, it is important to wear appropriate personal protective equipment (PPE) such as gloves, goggles, and lab coat. Work should be performed in a well-ventilated area or fume hood. Spills should be cleaned up immediately and handled in accordance with the safety data sheet (SDS). Ensure proper storage in a cool, dry place away from heat sources and incompatible materials.